LYC Healthcare Berhad (KLSE:LYC)
Malaysia · Delayed Price · Currency is MYR 0.0200
0.00 (0.00%)
At close: Jun 3, 2026
ACL Cables Cash Flow Statement
Financials in millions MYR. Fiscal year is April - March.
Millions MYR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | -23.27 | -17.07 | -20.78 | -19.19 | -9.23 |
Depreciation & Amortization | - | 17.61 | 15.45 | 9.29 | 7.61 |
Loss (Gain) From Sale of Assets | - | -1.81 | 0.05 | - | -0.15 |
Asset Writedown & Restructuring Costs | - | 3.56 | 0.89 | 1.1 | 0.01 |
Loss (Gain) From Sale of Investments | - | 0.33 | -0.8 | - | - |
Loss (Gain) on Equity Investments | - | 0.19 | 1.4 | 2.23 | 0.51 |
Provision & Write-off of Bad Debts | - | 0.22 | 1.28 | 0.23 | 0.19 |
Other Operating Activities | 40.46 | 17.15 | 12.82 | 14.43 | 7.76 |
Change in Accounts Receivable | - | -6.91 | -7.06 | -3.09 | -2.24 |
Change in Inventory | - | 1.98 | -0.91 | -1.9 | -0.34 |
Change in Accounts Payable | - | 14.04 | 4.42 | 1.82 | -3.13 |
Change in Unearned Revenue | - | -0.6 | 3.97 | 0.07 | -0.65 |
Change in Other Net Operating Assets | 7.07 | - | - | - | - |
Operating Cash Flow | 24.26 | 28.7 | 10.74 | 4.99 | 0.34 |
Operating Cash Flow Growth | -15.49% | 167.38% | 115.04% | 1351.16% | - |
Capital Expenditures | - | -5.65 | -5.7 | -2.53 | -2.88 |
Sale of Property, Plant & Equipment | 1.91 | 0.06 | 0.47 | 0 | 0.02 |
Cash Acquisitions | - | 5.3 | -10.98 | -30.66 | -31.7 |
Divestitures | - | - | - | 12.11 | - |
Investment in Securities | 0 | - | 0.09 | -1.13 | -6.6 |
Other Investing Activities | 0.24 | 0.81 | -9.63 | 10.08 | 3.36 |
Investing Cash Flow | 2.15 | 0.51 | -25.75 | -12.13 | -37.8 |
Long-Term Debt Issued | 0.34 | - | 0.56 | 11.03 | 0.17 |
Total Debt Issued | 0.34 | - | 0.56 | 11.03 | 0.17 |
Long-Term Debt Repaid | -23.67 | -22.04 | -18.81 | -6.41 | -4.94 |
Total Debt Repaid | -23.67 | -22.04 | -18.81 | -6.41 | -4.94 |
Net Debt Issued (Repaid) | -23.33 | -22.04 | -18.25 | 4.62 | -4.77 |
Issuance of Common Stock | 1.41 | - | 10.89 | 33.37 | 17.79 |
Other Financing Activities | -9.65 | -13.1 | -11.85 | -12.03 | 30.4 |
Financing Cash Flow | -31.58 | -35.14 | -19.21 | 25.95 | 43.42 |
Foreign Exchange Rate Adjustments | 1.52 | 0.55 | -1.25 | -0.44 | -0.05 |
Miscellaneous Cash Flow Adjustments | - | -1.1 | - | - | - |
Net Cash Flow | -3.65 | -6.47 | -35.48 | 18.37 | 5.92 |
Free Cash Flow | 24.26 | 23.06 | 5.03 | 2.46 | -2.54 |
Free Cash Flow Growth | 5.22% | 358.08% | 104.68% | - | - |
Free Cash Flow Margin | 18.08% | 14.82% | 3.90% | 2.67% | -3.93% |
Free Cash Flow Per Share | - | 0.03 | 0.01 | 0.00 | -0.01 |
Cash Interest Paid | - | 5.7 | 10.01 | 10.44 | 6 |
Cash Income Tax Paid | - | 3.84 | 4.06 | 3.95 | 3.14 |
Levered Free Cash Flow | 12.17 | 11.15 | 1.24 | 7.52 | -12.68 |
Unlevered Free Cash Flow | 18.99 | 17.84 | 7.16 | 14.53 | -7.2 |
Change in Working Capital | 7.07 | 8.51 | 0.42 | -3.1 | -6.36 |